These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6628165)

  • 21. Electrical and mechanical effects of amrinone on isolated guinea pig ventricular muscle.
    Kondo N; Shibata S; Kodama I; Yamada K
    J Cardiovasc Pharmacol; 1983; 5(6):903-12. PubMed ID: 6196561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amrinone relaxes potassium-induced contracture of failing right ventricular muscle of cats.
    Gaide MS; Fitterman WS; Wiggins JR; Myerburg RJ; Cameron JS; Bassett AL
    J Cardiovasc Pharmacol; 1983; 5(2):335-40. PubMed ID: 6188912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Positive inotropic effect of 3, 4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-qu inolinone (OPC-8212) in the dog with experimentally-induced right-sided heart failure.
    Hashimoto K; Yabuuchi Y; Yamashita S; Mori T
    Arzneimittelforschung; 1984; 34(3A):390-3. PubMed ID: 6540094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacology of the bipyridines: amrinone and milrinone.
    Alousi AA; Johnson DC
    Circulation; 1986 Mar; 73(3 Pt 2):III10-24. PubMed ID: 2417744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of amrinone on atrioventricular conduction in the intact canine heart.
    Nusrat A; Tepper D; Hertzberg J; Sonnenblick EH; Aronson RS
    J Clin Pharmacol; 1983 Jul; 23(7):257-65. PubMed ID: 6886027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies aimed at elucidating the mechanism of action of CI-914, a new cardiotonic agent.
    Weishaar RE; Quade M; Schenden JA; Boyd DK; Evans DB
    Eur J Pharmacol; 1985 Dec; 119(3):205-15. PubMed ID: 3004993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiotonic activity of amrinone--Win 40680 [5-amino-3,4'-bipyridine-6(1H)-one].
    Alousi AA; Farah AE; Lesher GY; Opalka CJ
    Circ Res; 1979 Nov; 45(5):666-77. PubMed ID: 39684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of some new positive inotropic agents in guinea pigs.
    van Meel JC
    Pharmacology; 1985; 31(1):1-10. PubMed ID: 3161096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Positive inotropic and vasodilating effects of amrinone and milrinone in isolated canine heart.
    Sys SU; Boels PJ; Brutsaert DL
    J Cardiovasc Pharmacol; 1987 Oct; 10(4):445-9. PubMed ID: 2444798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced relaxation and reduced positive inotropic effects of amrinone in ventricular muscle from cats with subacute heart failure. Implications for drug therapy.
    Bassett AL; Gaide MS; Lodge NJ; Cameron JS
    Adv Myocardiol; 1985; 6():629-36. PubMed ID: 2986264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of amrinone, a cardiotonic drug, on calcium movements in dog erythrocytes.
    Parker JC; Harper JR
    J Clin Invest; 1980 Aug; 66(2):254-9. PubMed ID: 7400314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Electrophysiological actions of amrinone in dogs with cardiac lesions.
    Piwonka RW; Healey JF; Canniff PC; Farah AE
    J Cardiovasc Pharmacol; 1983; 5(6):1052-7. PubMed ID: 6196554
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Side effects of amrinone therapy.
    LeJemtel TH
    Br Heart J; 1983 Nov; 50(5):499-500. PubMed ID: 6639823
    [No Abstract]   [Full Text] [Related]  

  • 34. Competitive inhibition of phosphodiesterase activity by amrinone: its implication in the cardiac effect of the drug.
    Carpenedo F; Floreani M; Cargnelli G
    Pharmacol Res Commun; 1984 Oct; 16(10):969-77. PubMed ID: 6095329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dual effects of amrinone and caffeine on cardiac contractility: positive versus negative inotropy.
    Malécot CO; Katzung BG
    Proc West Pharmacol Soc; 1984; 27():11-3. PubMed ID: 6494142
    [No Abstract]   [Full Text] [Related]  

  • 36. Interaction between amrinone and parathyroid hormone on bone in culture.
    Krieger NS; Stern PH
    Am J Physiol; 1982 Dec; 243(6):E499-504. PubMed ID: 7149021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effects of a new positive inotropic agent on heart failure of a cardiopulmonary preparation].
    Kabela E; Michaels DC; Felice EL
    Arch Inst Cardiol Mex; 1979; 49(5):892-907. PubMed ID: 398199
    [No Abstract]   [Full Text] [Related]  

  • 38. Molecular basis for the cardiovascular activities of amrinone and AR-L57.
    Hayes JS; Bowling N; Boder GB; Kauffman R
    J Pharmacol Exp Ther; 1984 Jul; 230(1):124-32. PubMed ID: 6086873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiac effects of amrinone on rabbit papillary muscle and guinea pig Langendorff heart preparations.
    Onuaguluchi G; Tanz RD
    J Cardiovasc Pharmacol; 1981; 3(6):1342-55. PubMed ID: 6173535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the effects of amrinone and sodium nitroprusside on haemodynamics, contractility, and myocardial metabolism in patients with cardiac failure due to coronary artery disease and dilated cardiomyopathy.
    Wilmshurst PT; Thompson DS; Juul SM; Jenkins BS; Coltart DJ; Webb-Peploe MM
    Br Heart J; 1984 Jul; 52(1):38-48. PubMed ID: 6743422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.